Annals of Neurology/
Annals Clinical Translational Neurology
The Oversight Committee works as the liaison between the Board of Directors, the Child Neurology Society, the publisher and editorial office. This Committee ensures that the editors receive editorial support from the publisher and manages the contract. The Committee does not have oversight over editorial content.
The primary function of the Audit Committee is to assist the ANA Board of Directors in fulfilling its oversight responsibilities of the audit and financial report process.
The Executive Committee is comprised of the officers of the Board of Directors and includes the following positions:
- Past President
- Vice President
This group has the authority to act on behalf of the Board of Directors when timely action is required subject to any prior directions and limitations imposed by the Board of Directors. The Executive Committee reports its actions and makes appropriate recommendations to the Board of Directors.
International Outreach Committee
The International Outreach Committee is responsible for enhancing the relationship of the ANA with the wider world of academic neurology and neuroscience that exists in a global context. This includes consideration of countries that are high-income but also a focus on countries that are low- and middle-income.
This group is also responsible for advancing the mission and vision of the ANA while partnering with academic neurologists and neuroscientists, as well as those in training in these fields, in countries outside of the USA.
The Investment Subcommittee analyzes the ANA’s investment portfolio in relation to current market conditions, the ANA’s Investment Policy document and the ANA’s current financial conditions and will make recommendations for possible changes in asset allocations.
The History Committee archives the history of the American Neurological Association and of neurology as a profession. The History Committee facilitates and encourages the development of historical research and education in the history of neurology.
Membership/Honorary Advisory Committee
This Committee reviews applications for membership and makes recommendations to the Board of Directors.
The Membership/Honorary Committee reviews the qualifications of candidates proposed for Honorary Membership and submits its recommendations to the Board of Directors at an interim meeting. The Committee may also propose candidates on its own initiative.
The Nominating Committee develops a slate of individuals for vacant officer and council positions, which is then submitted to the Board of Directors for approval. The final approved slate is submitted to the membership for vote. Members should have knowledge of the roles and responsibilities of the various elected positions and also of the individuals who have previously held these positions. Efforts should be made to increase diversity as well as potential progressions and successions.
Professional Development Committee
This Committee is responsible for a wide range of ANA sponsored education programs, symposia and awards. The overall intent of these activities is to encourage trainees and junior staff to pursue careers in neurology in general, and academic neurology in particular, to enhance the likelihood of their success in the field of academic neurology and to contribute to the overall education of neurologists and other physicians in the neurologic sciences. The following task forces and subcommittees report to this Committee.
Career Development Workshops Task Force
E-Advising Task Force
Interactive Lunch Workshops Task Force
Translational & Clinical Research Course Committee
Public Policy and Relations Committee
Most professional societies invest in educating the public and public policy makers. The investment is often a large percentage of the society’s operating budget if its members derive a significant portion of their business or personal income from the government. The U.S. Federal government purchases more than half of all clinical care and is the most important source of research support through a host of agencies including the NIH, DoD, VA, CDC, CMS, and AHRQ. The majority of ANA members received a significant portion of their income for research and clinical practice from the government and the ANA must therefore invest significantly in a well- developed and coordinated public policy effort that fully aligns with the Association’s mission of advancing academic neurology and the neurologic sciences. Members also provide representation on the AAN’s Ethics, Law and Humanities Committee.
Those members who represent the ANA membership on committees hosted by other organizations and institutions.
Scientific Program Advisory Committee
The ANA Scientific Program Advisory Committee (SPAC) is responsible for determining the educational activities included in the formal program of the Annual Meeting, including the overall design and flow of the program, the types of activities (e.g. symposia, poster sessions), and the specific content of activities. The SPAC carries out this charge in a manner that is consistent with all rules and guidelines of the ACCME. The Special Interest Group Subcommittee and Local Arrangements Subcommittee report to this Committee.
Special Interest Group Subcommittee
Local Arrangements Subcommittee
Technology & Communications Committee
Translational & Clinical Research Course Committee
Compared to fields such as oncology, cardiology and diabetes and metabolism, the clinical neurosciences currently lack well established pathways for providing this kind of training for fellows and junior faculty. The principal charge to the Translational and Clinical Research Course (TCRC) Committee is to plan an annual or periodic course focusing on the development of young clinical neuroscientists interested or engaged in translational or clinical research. The course is distinct from the NINDS/University of Rochester Clinical Research Course, which is designed to focus on middle-stage clinical trials. The two to three-day (approximately) course will engage selected residents, research fellows, and junior faculty members in an overview of the development of therapies, biomarkers and devices for neurological diseases. Most participants will be clinician-scientists from neurology (or neurosurgery) and most will not have already developed long-term research programs or funding, but they should have declared intentions to work in this field. We would anticipate that the course would attract junior faculty, fellows or graduating residents.